Results for Platform Development

1 - 10 of 145

Dr. Jolley's research lab is focused on visualizing and quantifying congenitally abnormal heart structures using 3D imaging with the driving goal of informing surgical and interventional planning in children and adults with congenital heart disease.

E-mail:

jolleym [at] chop.edu

Daniel P. Kelly, MD

Dr. Kelly’s research career began with deciphering the genetic basis of inborn errors in metabolism in children, followed by a series of breakthrough discoveries relevant to the diagnosis and treatment of common forms of heart failure in the general population.

E-mail:

dankelly [at] pennmedicine.upenn.edu

Jonathan A. Mitchell, PhD

The overarching goal of my research is to help prevent chronic diseases in later life, by focusing on energetic behaviors (sleep, diet, and physical activity) and their impact on body composition during growth and development.

E-mail:

mitchellj2 [at] chop.edu

Kristopher R. Bosse, MD

The cure rate for children with neuroblastoma is unacceptable, making it imperative that new therapies are developed. Dr. Bosse's laboratory is focused on discovering and developing new neuroblastoma cell surface immunotherapeutic targets. Along with his colleagues, Dr. Bosse's aim is to capitalize on the robust differential expression of these molecules with immune-based therapies and also define their mechanisms of overexpression and roles in tumorigenesis.

E-mail:

bosse [at] chop.edu

Nikolaos G. Sgourakis, PhD

Dr. Sgourakis’ research focuses on understanding the intricate molecular mechanisms that determine the vast repertoire of peptide antigens displayed by the proteins of the Major Histocompatibility Complex for immune surveillance by T cells and Natural Killer cells.

E-mail:

sgourakisn [at] chop.edu

Allison E. Curry, PhD, MPH

Dr. Curry's research focuses on the epidemiology and prevention of motor vehicle crashes in children and adolescents.

E-mail:

currya [at] chop.edu

Janet R. Reid, MD, FRCPC

Dr. Reid's main project is RADIAL, an adaptive learning education platform that houses filtered knowledge around all subspecialties and delivers a customized curriculum to the end-user using deep learning algorithms.

E-mail:

reidj [at] chop.edu

Amanda E. Bennett, MD, MPH

Dr. Bennett’s research interests include screening for medical and behavioral co-morbidities in individuals with developmental disabilities, with specific interest in improving screening and outcome measures for children with autism spectrum disorder.

E-mail:

bennettam [at] chop.edu

Laura Breda, PhD

Dr. Breda is developing safe, potentially curative genetic therapies for sickle cell disease and b-thalassemia.

E-mail:

bredal [at] chop.edu

Omar A. Banda, PhD

Omar Banda investigates therapeutic applications of novel nanoparticle delivery systems for the treatment of Fanconi Anemia.

E-mail:

bandao [at] chop.edu